Laboratory of Research and Development of Analytical Solutions (LIDSA), Department of Analytical Chemistry, Nutrition and Food Science, Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.
Key Laboratory of Agricultural and Animal Products Storage and Processing of Guizhou Province, College of Liquor and Food Engineering, Guizhou University, Guiyang 550025, China.
National Institute for Chemical-Pharmaceutical Research & Development-ICCF Bucharest, Vitan Av. nr. 112, 3rd District, 031299 Bucharest, Romania.
Department of Inorganic Chemistry, Physical-Chemistry & Electrochemistry, Faculty of Applied Chemistry and Materials Science, University "Politehnica" of Bucharest, Gheorghe Polizu Street nr. 1-7, 1st District, 011061 Bucharest, Romania.
National Institute for Chemical-Pharmaceutical Research & Development-ICCF Bucharest, Vitan Av. nr. 112, 3rd District, 031299 Bucharest, Romania.
Department of Inorganic Chemistry, Physical-Chemistry & Electrochemistry, Faculty of Applied Chemistry and Materials Science, University "Politehnica" of Bucharest, Gheorghe Polizu Street nr. 1-7, 1st District, 011061 Bucharest, Romania.
Department of Inorganic Chemistry, Physical-Chemistry & Electrochemistry, Faculty of Applied Chemistry and Materials Science, University "Politehnica" of Bucharest, Gheorghe Polizu Street nr. 1-7, 1st District, 011061 Bucharest, Romania.
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Medicine and Pharmacy Grigore T. Popa, Universitatii Street. nr. 16, 700115 Iasi, Romania.
Knowledge of global clarithromycin (CLA)-resistant rates of...
A comprehensive search was performed for relevant literature until April 2021 in PubMed, Embase, and Web of Science databases. Freeman-Tukey double arcsine transformation was performed to estimate the...
The meta-analysis included 248 articles. The prevalence of CLA-resistant...
Overall CLA resistance rate was 27.53%, worldwide. The difference in CLA resistance rate among the included studies can be due to several reasons such as differences in antibiotic prescription rates i...
To describe the pharmacology, efficacy, safety, and potential role of vonoprazan with amoxicillin or amoxicillin and clarithromycin for the treatment of...
PubMed, Embase, Cochrane Library, and ClinicalTrials.gov were searched using the terms: (vonoprazan OR voquezna) AND ("...
Studies assessing the efficacy and safety of vonoprazan with amoxicillin and/or clarithromycin were included and divided into 3 groups based on different comparisons between treatment regimens used in...
Ten clinical trials and 17 observational studies were included. Vonoprazan-based therapy demonstrated greater acid inhibition and similar or higher efficacy than proton-pump inhibitor (PPI)-based ther...
Proton-pump inhibitor-based therapies have not reached the desired successful eradication rate of 90% for...
Vonoprazan-based therapies were effective and well tolerated for the treatment of...
Objective Vonoprazan (VPZ), clarithromycin (CAM), metronidazole (MNZ) and VPZ, MNZ, and sitafloxacin (STFX) regimen are all established Helicobacter pylori eradication therapies for patients with peni...
Dual priming oligonucleotide-based multiplex polymerase chain reaction (DPO-PCR) has recently been used for both the detection of...
We retrospectively analyzed the electronic medical records of 184 patients who, between September 2019 and December 2020, received eradication therapy following detection of...
In the clarithromycin susceptible group, per-protocol analyses showed eradication rates of 87.5% (42/48; 95% confidence interval [CI], 77.1% to 95.8%) for 7-day therapy and 87.2% (41/47; 95% CI, 78.7%...
Compared to the 14-day therapy, 7-day eradication therapy is sufficient after DPO-PCR-based clarithromycin susceptibility testing....
Due to increasing antibiotic resistance, various Helicobacter pylori eradication regimens other than clarithromycin-based therapies have been proposed. However, detailed data on which therapies were e...
In this retrospective cohort study, we analysed data of 1721 patients and included 608 patients undergoing H. pylori eradication therapy at the Department of Gastroenterology at the University Hospita...
The most common therapy scheme (71% of all cases) was proton pump inhibitor (PPI)-amoxicillin-metronidazole, followed by PPI-amoxicillin-clarithromycin (21%) and PPI-metronidazole-clarithromycin (6%)....
Despite increasing clarithromycin resistance globally, there was no difference in the eradication success of clarithromycin- and non-clarithromycin-containing therapy regimens in Switzerland. As varyi...
Rosacea is a chronic inflammatory skin disease with a high incidence, and it leads to negative emotions such as inferiority complex, increased psychological pressure, and a greatly reduced quality of ...
Clarithromycin extended-release (CLA-ER) was used as companion drug to rifampicin (RIF) for Mycobacterium ulcerans infection in the intervention arm of a WHO drug trial. RIF enhances CYP3A4 metabolism...
The impacts of water chemistry properties including pH and dissolved organic carbon (DOC) on the ecotoxicity of active pharmaceutical ingredients (APIs) are increasingly evident. These impacts are a r...
Macrolide antibiotics are widely used to treat various infections such as pneumonia and sinusitis, and previous exposure to macrolides is presumed to be a risk factor for standard triple therapy failu...
From the Korea National Health Insurance Service (NHIS2021-1-775) database, a total of 46,160 patients who were tested for clarithromycin resistance of H. pylori from 2016 to 2019 in Korea were identi...
Clarithromycin resistance rate of H. pylori in Korea was 16.2%. A multivariate analysis revealed that female sex (OR: 1.472, p < .001), age > 50 years (OR: 1.340, p < .001), previous use of macrolide ...
The use of macrolide antibiotics and a recent diagnosis of respiratory disease might increase clarithromycin resistance of H. pylori....
